PEARTREE CLEANING SERVICES LIMITED
Company number 02045868 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: A (Excellent)
Explanation: Peartree Cleaning Services Limited exhibits the financial constitution of a peak-condition athlete. The business demonstrates exceptional cardiovascular strength through its robust cash generation, a fortified immune system via zero reliance on external debt, and steady muscle growth in the form of compounded net assets. While there are mild symptoms of margin compression due to external cost pressures (labour inflation), the company's overall vital signs are highly resilient.
Key Vital Signs
- Pulse (Cash Position): £7.57 Million (2025)
- Interpretation: The company's cash pulse is incredibly strong and rhythmic. Cash has grown year-on-year from £2.24M in 2018 to £7.57M in 2025. This indicates a business that breathes easily, with more than enough liquidity to meet its obligations without breaking a sweat.
- Blood Pressure (Leverage Ratio): Low & Healthy
- Interpretation: With Total Assets of £12.46M against Total Liabilities of just £4.29M, the company operates with very low financial blood pressure. There is no reliance on heavy debt, meaning the business isn't strained by high interest repayments.
- Muscle Mass (Net Assets): £8.91 Million (2025)
- Interpretation: Net assets have grown consistently every single year over the past 8 years, rising from £3.39M in 2018 to £8.91M in 2025. This represents a business that is steadily building financial strength and retaining its earnings effectively.
- Metabolism (Gross Profit Margin): 21.61% (2025)
- Interpretation: The gross margin remains incredibly stable (21.61% in 2025 vs 21.43% in 2024). Despite cost inflation, the company has successfully passed wage increases onto its clients, keeping its metabolic efficiency intact.
- Energy Output (EBITDA): £2.88 Million (2025)
- Interpretation: While still very healthy, EBITDA experienced a slight dip from £2.94M in 2024. This is akin to a mild reduction in stamina—revenue grew by 9%, but absolute profit dipped slightly, indicating that operating costs are rising slightly faster than top-line sales.
Diagnosis
The patient is in outstanding financial health, displaying the classic symptoms of a well-managed, organically grown enterprise.
Symptoms of Robust Health: The most prominent sign of vitality is the balance sheet. A near £7.6M cash reserve against minimal borrowings means the company is practically immune to sudden financial shocks or market viruses. Furthermore, the strategic decision to ensure no single client accounts for more than 10% of revenue acts as a superb diversification antibody—losing one client will not trigger a systemic failure. The board has also comfortably funded £1.09M in ordinary dividends, proving the business generates real, distributable wealth for its shareholders, not just paper profits.
Symptoms of Mild Distress: There are mild signs of operational fatigue in the profit margins. Although revenue grew by 9% and gross margins were maintained, the EBITDA fell slightly. This is a direct symptom of the macroeconomic "flu" going around—specifically, rising Employers National Insurance thresholds and broader labour cost inflation. Additionally, new client acquisition fell below target, suggesting the company's sales pipeline has been slightly sluggish, though it began recovering in Q4.
Prognosis
The future outlook for Peartree Cleaning Services Limited is highly positive. The company's strong cash reserves provide a massive buffer against economic uncertainty. With client retention above 95%, the baseline revenue is highly secure. The board forecasts low double-digit revenue growth for the 2025/26 financial year, supported by a strong order book and contracted wage uplifts. The transition to AI-enabled CRM systems and an all-electric vehicle fleet shows a forward-thinking approach that will keep the business competitive and fit for the future.
Recommendations
To maintain peak condition and address the minor symptoms of margin compression, the following "prescriptions" are recommended:
- Cardio Training for the Sales Pipeline: Since new client wins fell below target, the investment in a new CRM and a third Business Development Manager is the correct course of treatment. Monitor the ROI of this sales expenditure closely to ensure the cost of acquisition doesn't further erode EBITDA.
- Dietary Adjustments for Labour Costs: With rising Employers NI and Living Wage costs acting as a slow drain on profitability, continue to aggressively pass these costs onto clients where contracts allow. Explore further operational efficiencies (like the extended shifts mentioned) to reduce the administrative overhead of managing large numbers of part-time staff.
- Vitamin Diversification: The strategic pivot to diversify revenue so no client exceeds 10% is excellent. Continue this treatment to ensure no single customer becomes a financial dependency.
- Cash Management Therapy: With over £7.5M sitting in cash, the business may be slightly overweight in low-yielding assets. While it's excellent for peace of mind, consider whether a portion of these reserves could be invested in higher-yield instruments or reinvested more aggressively into the technology and ESG initiatives highlighted in the strategic report to drive future growth.